603 related articles for article (PubMed ID: 31343125)
1. The Therapeutic Mechanisms of Propolis Against CCl
Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
[TBL] [Abstract][Full Text] [Related]
3. Taxifolin, Extracted from Waste
Liu X; Liu W; Ding C; Zhao Y; Chen X; Ling D; Zheng Y; Cheng Z
Drug Des Devel Ther; 2021; 15():871-887. PubMed ID: 33664566
[TBL] [Abstract][Full Text] [Related]
4. Asiatic acid attenuates CCl
Wei L; Chen Q; Guo A; Fan J; Wang R; Zhang H
Int Immunopharmacol; 2018 Jul; 60():1-8. PubMed ID: 29702278
[TBL] [Abstract][Full Text] [Related]
5. New role and molecular mechanism of Gadd45a in hepatic fibrosis.
Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG
World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416
[TBL] [Abstract][Full Text] [Related]
6. Salvianolic acid A attenuates CCl
Wang R; Song F; Li S; Wu B; Gu Y; Yuan Y
Drug Des Devel Ther; 2019; 13():1889-1900. PubMed ID: 31213776
[No Abstract] [Full Text] [Related]
7. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
Hassan MH; Ghobara MM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):971-83. PubMed ID: 27245167
[TBL] [Abstract][Full Text] [Related]
9. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.
Xu P; Zhang Y; Liu Y; Yuan Q; Song L; Liu M; Liu Z; Yang Y; Li J; Li D; Ren G
Toxicol Appl Pharmacol; 2016 Jan; 290():43-53. PubMed ID: 26592322
[TBL] [Abstract][Full Text] [Related]
11. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
14. Antifibrotic Mechanism of Pinocembrin: Impact on Oxidative Stress, Inflammation and TGF-β /Smad Inhibition in Rats.
Said MM; Azab SS; Saeed NM; El-Demerdash E
Ann Hepatol; 2018 Mar; 17(2):307-317. PubMed ID: 29469035
[TBL] [Abstract][Full Text] [Related]
15. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
Liang B; Guo XL; Jin J; Ma YC; Feng ZQ
World J Gastroenterol; 2015 May; 21(17):5271-80. PubMed ID: 25954100
[TBL] [Abstract][Full Text] [Related]
17. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
18. Wogonoside Shows Antifibrotic Effects in an Experimental Regression Model of Hepatic Fibrosis.
Wang Q; Wen R; Lin Q; Wang N; Lu P; Zhu X
Dig Dis Sci; 2015 Nov; 60(11):3329-39. PubMed ID: 26130019
[TBL] [Abstract][Full Text] [Related]
19. Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy.
Bai F; Huang Q; Nie J; Lu S; Lu C; Zhu X; Wang Y; Zhuo L; Lu Z; Lin X
Cell Physiol Biochem; 2017; 44(2):436-446. PubMed ID: 29141243
[TBL] [Abstract][Full Text] [Related]
20. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
Xiu AY; Ding Q; Li Z; Zhang CQ
Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]